Effect of Irrigation With Antibiotic-containing Solutions on Postoperative Pain and Intra-canal Bacteria
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04035070 |
Recruitment Status :
Not yet recruiting
First Posted : July 29, 2019
Last Update Posted : October 14, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Necrotic Pulp | Combination Product: co-amoxiclav-clindamycin solution Combination Product: MTAD Combination Product: 2.5% sodium hypochlorite | Phase 4 |

Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 51 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double (Participant, Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | Effect of Irrigation With Antibiotic-containing Solutions Versus Sodium Hypochlorite on Postoperative Pain and Intra-canal Bacteria in Teeth With Necrotic Pulps (a Randomized Double-blind Clinical Trial) |
Estimated Study Start Date : | January 2021 |
Estimated Primary Completion Date : | June 2021 |
Estimated Study Completion Date : | June 2021 |
Arm | Intervention/treatment |
---|---|
Experimental: Root canal irrigation with co-amoxiclav-clindamycin solution
Alternate irrigation with 1 mL antibiotic-containing solution followed by 4 mL 2.5% sodium hypochlorite solution between each size instrument and the consequent one. The antibiotic-containing solution will be prepared by mixing equal quantities of 1.2 gm Co-amoxiclav solution and 600 mg Clindamycin solution at a ratio of 1:1 by volume.
|
Combination Product: co-amoxiclav-clindamycin solution
antibiotic-containing solution will be prepared by mixing equal quantities of 1.2gm Co-amoxiclav solution and 600mg Clindamycin solution at a ratio of 1:1 by volume to be used as a root canal irrigating solution |
Experimental: Root canal irrigation with MTAD
Irrigation with 5 mL MTAD irrigating solution for 5 minutes between each size instrument and the consequent one.
|
Combination Product: MTAD
mixture of 3% doxycycline hyclate, 4.25% citric acid and detergent (Tween 80) to be used as a root canal irrigating solution
Other Name: BioPure MTAD |
Active Comparator: Root canal irrigation with 2.5% sodium hypochlorite
Irrigation with 5 mL 2.5% sodium hypochlorite irrigating solution between each size instrument and the consequent one.
|
Combination Product: 2.5% sodium hypochlorite
It will be prepared by adding 10mL of sterile distilled water to 10mL of 5.25% sodium hypochlorite solution to be used as a root canal irrigating solution |
- postoperative pain: numerical rating scale [ Time Frame: up to 48 hours after the first visit ]intensity of pain by numerical rating scale from 0 to 10
- intra-canal bacterial count [ Time Frame: 72 hours after root canal preparation ]pre and post-instrumentation samples to count intra-canal bacteria (CFU/mL)

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 50 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
-
Maxillary/mandibular single-rooted permanent teeth:
- Diagnosed clinically with pulp necrosis.
- Absence of spontaneous pain.
- Normal/slight widening in the periodontal membrane space (PMS).
- Patients' acceptance to participate in the trial.
- Patients who can understand numerical rating scale (NRS) and can sign the informed consent.
Exclusion Criteria:
- Medically compromised patients: Pain levels and healing following treatment would be compromised as these patients show higher incidence of pain and lower healing rate.
- Patients with known allergy to penicillin or penicillin derivatives.
- Pregnant females: Avoid radiation exposure, anesthesia, and medication.
- If analgesics or antibiotics have been administrated by the patient during the past 24 hours preoperatively: Might alter their pain perception.
- Patients reporting bruxism or clenching: Avoid further pressure on an already inflamed tooth inducing subsequent irritation and inflammation.
- Teeth that show association with acute periapical abscess and swelling: Need special treatment steps which could involve additional visits with incision and drainage. Also, it could influence initiation and progression of postoperative pain.
- Greater than grade I mobility or pocket depth greater than 5mm. Need special surgical and/or periodontal therapy.
- Non-restorable teeth.
- Immature teeth.
- Radiographic evidence of periapical radiolucency, external or internal root resorption, vertical root fracture, perforation or calcification.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04035070
Contact: Michel K Elias, M.Sc. | +2 0122 553 5090 | michel.karam.5@gmail.com | |
Contact: Heba El-Asfouri, Ph.D. | +2 0100 527 6232 | heba.elasfouri@dentistry.cu.edu.eg |
Egypt | |
Endodontic Department - Faculty of Dentistry - Cairo University | |
Cairo, Egypt |
Principal Investigator: | Michel K Elias, M.Sc. | Cairo University | |
Study Director: | Maged M Negm, Ph.D. | Cairo University | |
Study Chair: | Heba El-Asfouri, Ph.D. | Cairo University |
Responsible Party: | Michel Karam Eissa Elias, Assistant lecturer at endodontic department - School of dentistry - New Giza University, Cairo University |
ClinicalTrials.gov Identifier: | NCT04035070 |
Other Study ID Numbers: |
CEBC-CU-2019-10-145 |
First Posted: | July 29, 2019 Key Record Dates |
Last Update Posted: | October 14, 2020 |
Last Verified: | October 2020 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | Yes |
Studies a U.S. FDA-regulated Device Product: | No |
Product Manufactured in and Exported from the U.S.: | Yes |
antibiotic-containg solution co-amoxiclav-clindamycin solution MTAD sodium hypochlorite |
postoperative pain antimicrobial efficacy root canal irrigation |
Dental Pulp Necrosis Pain, Postoperative Necrosis Postoperative Complications Pathologic Processes Pain Neurologic Manifestations Dental Pulp Diseases Tooth Diseases Stomatognathic Diseases Clindamycin Clindamycin palmitate |
Clindamycin phosphate Amoxicillin-Potassium Clavulanate Combination Sodium Hypochlorite Eusol Anti-Bacterial Agents Anti-Infective Agents Protein Synthesis Inhibitors Enzyme Inhibitors Molecular Mechanisms of Pharmacological Action Disinfectants beta-Lactamase Inhibitors |